PHS
RYTM icon

PFM Health Sciences’s Rhythm Pharmaceuticals RYTM Stock Holding History

PFM Health Sciences’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Sell
101,550
-35,071
-26% -$3.17M 0.97% 39
2026
Q1 		$11.9M Buy
136,621
+96,411
+240% +$9.38M 1.08% 30
2025
Q4 		$4.3M Sell
40,210
-7,952
-17% -$844K 0.43% 56
2025
Q3 		$4.86M Buy
+48,162
New +$4.47M 0.37% 50

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PFM Health Sciences's RYTM Position: Q2 2026 in Review

PFM Health Sciences reduced its Rhythm Pharmaceuticals (RYTM) stake by 26% in Q2 2026, selling an estimated $3.17M and leaving 101,550 shares worth $11.3M. The position accounts for 0.97% of the portfolio, ranked #39.

PFM Health Sciences first reported a position in RYTM in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.9M in Q1 2026. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • PFM Health Sciences held 101,550 shares of Rhythm Pharmaceuticals worth $11.3M as of Q2 2026.
  • PFM Health Sciences sold 35,071 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $3.17M.
  • Rhythm Pharmaceuticals made up 0.97% of PFM Health Sciences's portfolio in Q2 2026, its #39 holding.
  • PFM Health Sciences first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • PFM Health Sciences's Rhythm Pharmaceuticals position peaked at $11.9M in Q1 2026.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.